From bench to bedside: Advancements in urological oncology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

From bench to bedside: Advancements in urological oncology

Published:2024-09 Issue: Volume: Page:
ISSN:2949-7132
Container-title:Cancer Pathogenesis and Therapy
language:en
Short-container-title:Cancer Pathogenesis and Therapy

Author:

Niu Shaoxi,Zhang Yaoguang,Huang Hai,Ma Xin^ORCID

Publisher

Elsevier BV

Reference5 articles.

1. Epidemiology and prevention of prostate cancer;Gandaglia;Eur Urol Oncol,2021

2. Emerging role of transforming growth factor-β-regulated long non-coding RNAs in prostate cancer pathogenesis;Shree;Cancer Pathog Ther,2023

3. Integrative analysis of cuproptosis-related lncRNAs: Unveiling prognostic significance, immune microenvironment, and copper-induced mechanisms in prostate cancer;Zhong;Cancer Pathog Ther,2024

4. Chimeric RNAs and their implication in prostate cancer;Li;Cancer Pathog Ther,2023

5. 3D augmented reality during Retzius-sparing robot-assisted radical prostatectomy (RS-RARP): First experience;Secco;Cancer Pathog Ther,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP